Finance

Beta
Lists
ANVS:NYSE
Annovis Bio Inc
$1.77
+1.14%
(+0.020) 1D
Jun 22, 4:00:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANVS...
Open
$1.78
High
$1.84
Low
$1.73
Mkt. cap
61.32M
Avg. vol.
1.19M
Volume
0.00
52-wk high
$5.50
52-wk low
$1.54
EPS
-$1.70
Beta
1.27
Shares outstanding
42.54M
No. of employees
8
Open
$1.78
High
$1.84
Low
$1.73
Mkt. cap
61.32M
Avg. vol.
1.19M
Volume
0.00
52-wk high
$5.50
52-wk low
$1.54
EPS
-$1.70
Beta
1.27
Shares outstanding
42.54M
No. of employees
8
News stories
From sources across the web
About Annovis Bio Inc
CEOMaria-luisa Maccecchini
Employees8
Founded2008
HeadquartersMalvern, Pennsylvania, United States
SectorBiotechnology
Websiteannovisbio.com
Analyst Ratings
Based on 2 analysts giving stock ratings to ANVS in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ANVS in the last 3 months.
Highest
Current $1.77
$17.00 (+860.45%)
Average
$12.50 (+606.21%)
Lowest
$8.00 (+351.98%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Reiterated
$8.00
+352%
05/28/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
$17.00
+860.5%
04/14/2026
Last report
May 15, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.63 / -$0.36
-75.00%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.01M
5.16M
6.29M
8.75M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.27M
1.11M
1.14M
955.15K
Operating expense
6.28M
6.27M
7.43M
9.71M
Total operating expenses
6.28M
6.27M
7.43M
9.71M
Operating income
-6.28M
-6.27M
-7.43M
-9.71M
Other non operating income
558.00K
-140.00K
20.00K
-296.00K
EBT including unusual items
-5.54M
-6.22M
-7.26M
-9.83M
EBT excluding unusual items
-5.54M
-6.22M
-7.26M
-9.83M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.54M
-6.22M
-7.26M
-9.83M
Net profit margin
-
-
-
-
Earnings per share
-0.32
-0.32
-0.37
-0.39
Interest and investment income
187.61K
191.40K
152.32K
167.74K
Interest expense
-
-
-
-
Net interest expenses
187.61K
191.40K
152.32K
167.74K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer